Healthcare -
Biotechnology - NASDAQ - US
$ 2.43
0.206 %
$ 70.2 M
Market Cap
-0.81
P/E
Price Target
Average
969.96%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
36.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aerovate Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AVTE of $26 , with forecasts ranging from
a
low of
$2 to a high of $65 .
AVTE Lowest Price Target
Wall Street Target
2 USD
-17.70%
AVTE Average Price Target
Wall Street Target
26 USD
969.96%
AVTE Highest Price Target
Wall Street Target
65 USD
2574.90%
REVENUE FORECAST
Revenue Forecast Chart AVTE
EBIT FORECAST
EBIT Forecast Chart AVTE
NET INCOME FORECAST
Net Income Chart AVTE